Coronary disease & ACS

Prophylactic Venoarterial Extracorporeal Membrane Oxygenation (VA-ECMO) During Complex High-Risk Percutaneous Coronary Intervention (PCI): A Randomized Controlled Trial

JACC AdvPublished randomized trial

Authors' conclusion

In this single-center study of patients undergoing elective PCI of complex high-risk coronary lesions, prophylactic VA-ECMO was associated with lower rates of life-threatening complications and larger reduction in SYNTAX scores. Larger studies are needed to further define optimal management strategies in high-risk complex PCI.

Study context

Population
Patients with complex high-risk coronary lesions (SYNTAX score ≥33) who declined coronary artery bypass grafting, undergoing elective PCIwomen: 14.3%, enrolled between June 2021 and August 2023
Participants
70 patients
Comparison
Prophylactic VA-ECMO vs no prophylactic VA-ECMO during elective PCI
  • VA-ECMOn = 34
  • Controln = 36
Primary endpoint
Rate of complications during PCI (life-threatening complications) and SYNTAX score reduction post-PCI
Methodological detailssingle-center
  • Single-center

Primary result

As reported in the abstract

Life-threatening complications

OutcomeVA-ECMOControl
Absolute reduction in SYNTAX score27.2 [24.5-35.0]22.5 [11.5-32.8]

Further findings

OutcomeVA-ECMOControl
Baseline SYNTAX score · pre-PCI37.8 [34.5-44.0]35.8 [33.2-40.8]
Emergency VA-ECMO— not stated in the abstract19.4%

— not stated in the abstract

  • Baseline SYNTAX score: similar, P = 0.11

Original publication

Prophylactic VA-ECMO During Complex High-Risk PCI: A Randomized Controlled Trial. JACC Adv. Published 22 August 2025. doi:10.1016/j.jacadv.2025.102095

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.